Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD
0.373
+0.018 (4.95%)
At close: Oct 4, 2022 4:00 PM
0.402
+0.029 (7.77%)
After-hours: Oct 4, 2022 4:55 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Selling, General & Admin
9.345.074.286.620.810.26
Research & Development
8.45.853.970.370.180.15
Other Operating Expenses
1.5500000
Operating Expenses
19.2910.938.246.9910.41
Operating Income
-19.29-10.93-8.24-6.99-1-0.41
Interest Expense / Income
0001.170.140.01
Other Expense / Income
0.23-0.030.353.48-0-0
Pretax Income
-19.52-10.89-8.59-11.63-1.14-0.42
Income Tax
-0.0900000
Net Income
-19.42-10.89-8.59-11.63-1.14-0.42
Net Income Common
-19.42-10.89-8.59-11.63-1.14-0.42
Shares Outstanding (Basic)
191210533
Shares Outstanding (Diluted)
191210533
Shares Change
49.15%26.50%107.01%45.80%0.20%-
EPS (Basic)
-1.04-0.87-0.87-2.44-0.35-0.13
EPS (Diluted)
-1.04-0.87-0.87-2.44-0.35-0.13
Free Cash Flow Per Share
-0.65-0.61-0.64-0.53-0.15-0.08
Effective Tax Rate
0.48%0.00%0.00%0.00%0.00%0.00%
EBITDA
-19.46-10.89-8.59-10.46-0.99-0.41
Depreciation & Amortization
0.0600000
EBIT
-19.52-10.89-8.59-10.46-0.99-0.41
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).